| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.049 | 0.3 |